They either need to grow quickly (to eventually be profitable) or wind up operations completely.
No point treading water at a (smaller) loss as eventually raising capital to stay afloat won't be possible.
I'd anticipate the acquisition will be a complete change of direction.
- Forums
- ASX - By Stock
- CF1
- Ann: Intiger Market Update
Ann: Intiger Market Update, page-246
Featured News
Add CF1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.92M |
Open | High | Low | Value | Volume |
2.1¢ | 2.1¢ | 2.1¢ | $9.765K | 465K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 545246 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 358735 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 545246 | 0.020 |
1 | 688535 | 0.019 |
1 | 345696 | 0.018 |
3 | 1252000 | 0.017 |
1 | 1000000 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 358735 | 2 |
0.022 | 1000000 | 1 |
0.044 | 500000 | 1 |
0.060 | 17225 | 1 |
0.090 | 6007 | 1 |
Last trade - 10.05am 03/07/2024 (20 minute delay) ? |
Featured News
CF1 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online